生物学的製剤等の製造所におけるバイオセーフティの取扱いに関する指針
-
- 小松 俊彦
- NPO 法人バイオメディカルサイエンス研究会
書誌事項
- タイトル別名
-
- Biosafety Guidelines at Biological Substance Production Facilities
抄録
In recent years, in Japanese society, Medical practice, medicines, foods, and environmental accidents and natural disasters have been happening. The importance of “Danger management” has been realized, and its system has been strongly sought. On the other hand, even about contagious diseases, treatment with sulfa drugs and/or antibiotics, and inoculation with vaccines have advanced in development. In the developed countries, contagious disease had been thought to be almost conquered. Nevertheless, in the past 20 years about 30 new infectious diseases have appeared, and the previous diseases also have gained immunity to medicines by changing character and virology, reappearing as new diseases and are looked upon as problems. Especially concerning infectious diseases, the importance of controlling dangers such as HIV infected blood plasma goes without saying. With this background, concerning the increasingly sought biosafely, biological production facilities biohazards counterplans sighted as basic lectures are to be conducted. The lecture content is dealing with biohazards, and biosafety principles and practices, and biosafety guideline in bioproduction facilities.<br>
収録刊行物
-
- 日本PDA学術誌 GMPとバリデーション
-
日本PDA学術誌 GMPとバリデーション 3 (1), 8-12, 2001
一般社団法人日本PDA製薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282679448934016
-
- NII論文ID
- 130004851474
-
- DOI
- 10.11347/pda.3.8
-
- ISSN
- 18811728
- 13444891
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可